IL33 and atherosclerosis: Miller et al. investigated possible effects of IL-33 in murine atherosclerosis and demonstrated that injection of a high dose of IL-33 (1 μg/injection twice per week) for 6 weeks into atherosclerosis-prone ApoE−/− mice reduced the development of atherosclerotic lesions in the aortic sinus [35].